Maintenance rituximab in Veterans with follicular lymphoma

Abstract Real‐world practice patterns and clinical outcomes in patients with follicular lymphoma (FL), including the adoption of maintenance rituximab (MR) therapy in the United States (US), have been reported in few studies since the release of the National LymphoCare Study almost a decade ago. We...

Full description

Bibliographic Details
Main Authors: Ahmad S. Halwani, Kelli M. Rasmussen, Vikas Patil, Deborah Morreall, Catherine Li, Christina Yong, Zachary Burningham, Keith Dawson, Anthony Masaquel, Kevin Henderson, Elisha DeLong‐Sieg, Brian C. Sauer
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.3420